Medicine and Dentistry
Patient
100%
Child
96%
Pediatrics
44%
Venous Thromboembolism
38%
Thrombosis
36%
Bleeding
35%
Post-Thrombotic Syndrome
33%
Diseases
32%
Complication
30%
Extracorporeal Membrane Oxygenation
28%
Therapeutic Procedure
27%
Coagulation
24%
Childhood
22%
Phlebothrombosis
21%
Catheter Thrombosis
18%
Thrombophilia
18%
Pulmonary Embolism
17%
Central Venous Catheter
17%
Age
17%
Pediatrics Patient
16%
Incidence
16%
Development
16%
Protein S Deficiency
15%
Thromboembolism
15%
Odds Ratio
14%
Anticoagulation
13%
Home Parenteral Nutrition
12%
Diagnosis
12%
Combination Therapy
12%
Survival
12%
Estrogen Therapy
12%
Thromboprophylaxis
12%
Blood Stasis
11%
Supportive Care
11%
Thrombocytopenia
11%
Physical Examination
11%
Meta-Analysis
10%
Observational Study
10%
Heparin
10%
Prophylaxis
10%
Antibody
10%
Antithrombin
9%
Protein S
9%
Propofol
9%
Etomidate
9%
Systemic Vascular Resistance
9%
Thrombotic Thrombocytopenic Purpura
9%
Ciclonicate
9%
Fibrinogen Concentrate
9%
Tachypnea
9%
Nursing and Health Professions
Extracorporeal Oxygenation
21%
Confidence Interval
20%
Child
20%
Complication
20%
Bleeding
17%
Thrombosis
14%
Venous Thromboembolism
14%
Control
12%
Procedures
10%
Parameters
9%
Odds Ratio
9%
Pediatrics
9%
Thromboembolism
9%
Sodium Thiopental
9%
Etomidate
9%
Girl
9%
Systemic Vascular Resistance
9%
Propofol
9%
Systematic Review
9%
Central Venous Catheter
9%
Anticoagulation
8%
Disability
8%
Neonates
7%
Combination Therapy
7%
Estrogen Therapy
7%
Thrombotic Thrombocytopenic Purpura
7%
Centrifugal Pump
7%
Protein S Deficiency
6%
Consensus
6%
Hemostatic Agent
6%
Patient
5%
Craniofacial Synostosis
5%
Placebo
5%
Pump
5%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
21%
Bleeding
19%
Nadroparin
18%
Heparin
12%
Fibrinogen Concentrate
9%
Ciclonicate
9%
Case-Control Study
9%
Antiphospholipid Antibody
9%
Complication
9%
Thromboembolism
8%
Randomized Controlled Trial
8%
Malignant Neoplasm
7%
Thrombosis
6%
Thrombin Inhibitor
6%
Recombinant Blood Clotting Factor 7a
6%
Protein S Deficiency
6%
Antibiotic Agent
5%
Hemophilia A
5%
Anticoagulant Agent
5%
Craniofacial Synostosis
5%